| |
|
|
|
Celldex Therapeutics Inc.  
|
|
0.33 -0.007 (-0.02%) |
11-16 16:00 |
|
Open: |
0.3426 |
Pre close: |
0.337 |
Target:
|
0.48
|
|
High: |
0.3498 |
Low: |
0.33 |
Resistance:
|
0.41
0.48
|
|
Volume: |
1,092,375 |
Market Cap: |
57M |
Support:
|
0.30
0.25
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.34
 |
MACD |
MACD(12,26):
|
-0.02  |
|
MA(20): |
0.34 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
0.44 |
Stochastic Oscillator |
%K(14,3):
|
33.33 |
|
MA(250): |
1.35 |
%D(3): |
35.56 |
|
Average Volume(K) |
3-Month: |
160232
|
52-Week |
High:
|
3.09 |
|
10-Days: |
189132 |
Low: |
0.30 |
|
RSI |
RSI(14):
|
40.64 |
Change(%): |
-88.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.550 |
Return on Equity (ttm) |
-91.7 |
Shares Out. (M) |
172.47 |
|
EPS Est. Current Year |
-1.040 |
Return on Assets (ttm) |
-62.8 |
Shares Float (M) |
165.80 |
|
EPS Est. Next Year |
-0.950 |
PEG Ratio |
0.00 |
% Held by Insiders |
4.60 |
|
EPS Est. Next Quarter |
-0.280 |
Qtrly Rev. Growth |
-27.8 |
% Held by Institutions |
39.90 |
|
Forward EPS |
-0.818 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.510 |
EBITDA (p.s.) |
0.000 |
P/E |
-0.60 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.65 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-89.30 |
P/S |
536052032.00 |
|
Operating Margin |
-679.72 |
Levered Free Cash Flow
(M) |
-55.86 |
P/CF |
-0.64 |
|
|
|
|
|
|
